Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **intestinal epithelium barrier function** is not a single molecule or receptor but rather the collective property of the intestinal epithelial layer that separates the contents of the gut lumen from underlying tissues. This function is achieved by specialized epithelial cells—such as enterocytes, goblet cells, Paneth cells, enteroendocrine cells, and microfold cells—which together form a physical and biochemical defense against pathogens while allowing selective absorption of nutrients[1][4]. The integrity and permeability of this barrier are regulated by intercellular junctional complexes including tight junctions (TJs), adherens junctions (AJs), and desmosomes. Key TJ proteins include occludin, claudins, zonula occludens proteins (ZO‑1/2/3), tricellulin, and junctional adhesion molecules[1][2][3]. Disruption in these structures can lead to increased intestinal permeability ("leaky gut"), contributing to inflammation or infection[3]. The regulation involves complex signaling pathways such as Wnt/β-catenin for cell proliferation/homeostasis and MAPK/NFκB for inflammatory responses[3]. Because "intestinal epithelium barrier function" describes an emergent property rather than a discrete druggable target like an enzyme or receptor—and encompasses many molecular components—it should not be considered a canonical therapeutic target itself. Instead, individual molecules within this system may serve as specific targets for drugs aiming to modulate intestinal permeability or treat related diseases. > "The term 'intestinal barrier' emphasizes the barrier function... which protects organism against invading by bacteria... Epithelial cells are connected by TJ proteins... which regulate absorption..." [1] > "Intestinal barrier function is achieved by distinct epithelial junctional complexes encompassing TJ [tight junction], AJ [adherens junction], and DMs [desmosomes]..." [2] > "Epithelial cells play a crucial role in the mechanical barrier... maintaining its integrity... restoration ... can potentially be achieved ... with compounds that inhibit NFκB and MLCK." [3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelium barrier function.